View Older Stories View More Recent Stories

Feb 24, 2017 01:25PM Pharma Stocks on Watch as Draft Obamacare Reform Bill Makes No Mention of Drug Prices - Evercore's Raffatt
Feb 22, 2017 04:19PM Evercore ISI Starts Jazz Pharmaceuticals (JAZZ) at Buy
Feb 3, 2017 08:22AM Impax Laboratories (IPXL) Generic EpiPen Shows 'Meaningful Gains' Versus Mylan's EpiPen - Evercore ISI Raffat
Jan 20, 2017 07:51AM Generics File Against New Teva Pharma (TEVA) Copaxone 40MG Patent - Evercore ISI
Jan 10, 2017 09:49AM Valeant Pharma (VRX): 'Finally Some Good News' - Evecore ISI's Raffat
Jan 3, 2017 07:13AM Allergan (AGN) on Watch After Raising Drug Prices
Dec 29, 2016 01:26PM Allergan (AGN) Sees Sneaky Gains Into Year-End After Disastrous 2016
Dec 13, 2016 11:22AM Allergan (AGN) Has an Important Catalyst Forthcoming that is Flying Under the Radar - Evercore ISI's Raffat
Nov 15, 2016 01:10PM Medicines Co. (MDCO) Recovers; Evercore ISI's Raffat Says Data 'Looks Very Consistent and Durable'
Nov 8, 2016 10:03AM Biggest Takeaway from Valeant (VRX) Call is 2017 Revs and EBITDA Expected to Be Below 2016 - Evecore ISI's Raffat
Nov 8, 2016 07:53AM Valeant Pharma (VRX) EBITDA Was North of $1B, Which Was Better than Feared - Evecore ISI Raffat
Nov 2, 2016 06:56AM Allergan CEO takes blame for big miss on quarterly earnings
Oct 6, 2016 04:45PM Evercore ISI named # 3 in U.S. Equity Research by Institutional Investor's All-America Equity Research Survey
Sep 29, 2016 12:01PM Valeant Pharma (VRX), Other Pharma Stocks Weaker as Clinton Op-Ed Discusses Measures on Drug Prices
Sep 29, 2016 11:50AM Allergan (AGN) Namenda Concerns 'Not a Big Deal' - Evecore ISI's Raffat
Sep 28, 2016 10:33AM Evercore ISI Raffat Highlights New Development on Teva Pharma (TEVA) from Copaxone Hearing
Sep 14, 2016 09:46AM Mylan CEO to testify before House panel over EpiPen pricing
Sep 7, 2016 11:24AM 1997 CMS Letter to Mylan (MYL) Shows Evidence of EpiPen Medicaid Rebate - Evecore ISI's Raffat
Aug 29, 2016 07:45AM Evercore ISI Starts Theravance Biopharma (TBPH) at Buy
Aug 26, 2016 07:47AM Why All the Outcry About EpiPen Prices Now? It's Back to School Time
Aug 25, 2016 11:46AM Mylan's (MYL) EpiPen Saga Could Add More Supply Chain Volatility Moving Forward - Evercore
Aug 24, 2016 02:00PM Senate Hearing on Mylan (MYL) EpiPen Pricing Likely in the Works - Evercore ISI
Aug 22, 2016 04:48PM Epipen Pricing Debate Has Mylan (MYL) Investors on Edge
Aug 8, 2016 01:57PM All Eyes on Valeant Pharma (VRX) EBITDA, Which is Expected to be Lowered - Evecore ISI's Raffat
Aug 2, 2016 10:54AM Medicines Co. (MDCO) on Watch as Pfizer Backs Off Competitive PCSK9
Jul 11, 2016 11:22AM Medicines Co. (MDCO): Market Under-Estimating What Angiomax Decision Means - Evercore ISI
Jul 6, 2016 02:59PM EU Divestiture Not Required Before Allergan (AGN)/Teva Pharma (TEVA) Close - Evecore ISI's Raffat
Jun 27, 2016 10:12AM Medicines Co. (MDCO) Gains Amid Positive Analyst Call
Jun 8, 2016 06:13PM Evecore ISI's Raffat Not Worried About New Alkermes plc (ALKS) IPR Challenge
Jun 7, 2016 08:06AM Valeant Pharma (VRX) EBITDA Guidance Just Above Maintenance Covenants - Evercore ISI's Raffat
Jun 6, 2016 10:33AM Mylan NV (MYL): Another Epipen Competitor Delayed, Possible Catalyst for EPS Increases - Evercore ISI
Jun 1, 2016 10:43AM Alkermes (ALKS) Data Shines Positive Light on Phase 3 Trial Miss - Evecore ISI
May 5, 2016 01:00PM Medicines Co. (MDCO) Gains as En Banc Hearing Said to Have 'Went Well'
Apr 19, 2016 01:05AM Debt-laden Valeant faces tough choices in asset sales
Apr 19, 2016 01:05AM Debt-laden Valeant faces tough choices in asset sales
Apr 13, 2016 11:37AM Evercore ISI Defends Allergan (AGN) Following Negative Report
Apr 12, 2016 11:39AM Synthon's Generic Copaxone 20mg Approved in Europe Today - Analyst (TEVA)
Apr 4, 2016 05:01PM New U.S. inversion rules threaten Pfizer-Allergan deal
Mar 31, 2016 12:17PM FDA Puts Out Guidance on Biosimilar Labeling
Mar 28, 2016 09:22AM Apricus Bio's (APRI) ALD403 Data is Positive, But May Not Compare to Prior Teva Data - Evercore
Mar 15, 2016 10:56AM Valeant Pharma (VRX) Results Suggest Disruption in the Business - Evecore ISI's Raffat
Mar 15, 2016 08:15AM The Single Most Important Catalyst for Valeant Pharma (VRX) Near-Term...
Mar 15, 2016 06:20AM Drugmaker Valeant faces debt default risk; shares plunge 50 percent
Feb 29, 2016 10:42AM Valeant shares slide on news of probe by U.S. SEC
Feb 28, 2016 09:10PM Valeant CEO Pearson to return effective immediately, results delayed
Feb 23, 2016 11:55AM Valeant shares jump 9 percent after announcement of plans to restate
Feb 12, 2016 08:13AM Valeant Pharma (VRX) TRx Continues Gains in Week 3 of Walgreens Deal - Evecore ISI
Feb 5, 2016 08:12AM Valeant Pharma (VRX) IMS Script Data Remains Strong in Week 2 Post-Walgreens - Evercore ISI
Feb 3, 2016 02:11PM 'No Blatant Lies' Seen from Valeant (VRX) CEO/CFO Exchange and Philidor Scripts Were Not Just Smoke and Mirrors - Evercore ISI
Feb 2, 2016 12:29PM Evercore ISI Follows Up on Valeant Pharma (VRX) Response to Questions
View More Recent Stories View Older Stories